| ²é¿´: 310 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
chzhbin½ð³æ (Ö°Òµ×÷¼Ò)
|
[½»Á÷]
·ÒëÇóÖú£¡¼±£¡Ð»Ð»°¡£¡Ó¢Ò뺺£¡
|
||
|
There may be reasons to deviate from the TTC value based on the profile of genotoxicity results. Positive result from in vitro studies only may allow to exempt an impurity from limitation at TTC level if lack of in vivo relevance of the findings is convincingly demonstrated based on a weight-of evidence approach (see ICH S2 guidelines). This approach will usually need negative results with the impurity from some additional in vitro and/or appropriate in vivo testing. |
» ²ÂÄãϲ»¶
302·Ö 085601Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ6È˻ظ´
318Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ6È˻ظ´
0703»¯Ñ§µ÷¼Á325·Ö
ÒѾÓÐ8È˻ظ´
ÉúÎ﹤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
290Çóµ÷¼Á085701
ÒѾÓÐ10È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ14È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
283·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
wangwei2008
ľ³æ (Ö°Òµ×÷¼Ò)
Сľ³æÖ®ÒÆ»¨¹¬Ö÷
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 4264.6
- É¢½ð: 1
- ºì»¨: 1
- Ìû×Ó: 4265
- ÔÚÏß: 152.7Сʱ
- ³æºÅ: 495631
- ×¢²á: 2008-01-15
- רҵ: Ö²ÎïÉúÀíÓëÉú»¯
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
chzhbin(½ð±Ò+10,VIP+0): 9-13 17:19
chzhbin(½ð±Ò+10,VIP+0): 9-13 17:19
|
רҵ²»¶Ô¿Ú£¬·ÒëµÄ²»ºÃ£¬»¹Íû¼ûÁ£¡ Æ«Àë»ùÓÚÒÅ´«¶¾ÐÔ½á¹ûͼµÄTTCÖµ¿ÉÄÜÊÇÓÐһЩÔÒòµÄ¡£Èç¹ûȱ·¦¿ÉÒÔÁîÈËÐÅ·þµØÖ¤Ã÷ÊÇ»ùÓÚa weight-of evidence approachµÄÌåÄÚÏà¹ØµÄÑо¿½á¹û£¬ÌåÍâÑо¿µÄÑôÐÔ½á¹û¿ÉÄÜÖ»ÄÜÅųýÔÚTTCˮƽÉϵÄÏÞ¶¨·¶Î§µÄÔÓÖÊ¡£ÕâÖÖ·½·¨Í¨³£ÐèҪһЩÀ´×ÔÓÚÆäËûÔÚÌåÍâºÍ/»òÊʵ±µÄÌåÄÚÊÔÑéµÄÒõÐÔ½á¹û¡£ |
2Â¥2009-09-13 17:14:43
pds
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3823.7
- Ìû×Ó: 255
- ÔÚÏß: 35.9Сʱ
- ³æºÅ: 657214
- ×¢²á: 2008-11-18
- רҵ: ½á¹¹¹¤³Ì
3Â¥2009-09-13 18:30:30














»Ø¸´´ËÂ¥